Sale!

FBN1 Gene Geleophysic Dysplasia Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

Geleophysic Dysplasia Type 2, a rare genetic condition, is characterized by distinctive facial features, short stature, and problems with the heart, bones, and other parts of the body. This condition is linked to mutations in the FBN1 gene, which plays a crucial role in the development and function of connective tissues throughout the body.

To diagnose this specific form of Geleophysic Dysplasia, a genetic test targeting the FBN1 gene can be conducted. DNA Labs UAE offers this specialized testing service to identify mutations in the FBN1 gene that are associated with Geleophysic Dysplasia Type 2. The test is a crucial step for accurate diagnosis, enabling tailored medical management and genetic counseling for affected individuals and their families.

The cost of the FBN1 Gene Geleophysic Dysplasia Type 2 Genetic Test at DNA Labs UAE is 4400 AED. This test is a valuable tool for healthcare providers in diagnosing this rare condition, facilitating early intervention and support for patients.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FBN1 Gene Geleophysic dysplasia type 2 Genetic Test

Test Name: FBN1 Gene Geleophysic dysplasia type 2 Genetic Test

Components: FBN1 Gene Geleophysic dysplasia type 2 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Dysmorphology

Doctor: Pediatrics

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for FBN1 Gene Geleophysic dysplasia type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FBN1 Gene Geleophysic dysplasia type 2 NGS Genetic DNA Test gene FBN1

Test Details:

The FBN1 gene is associated with a genetic disorder called Geleophysic dysplasia type 2. Geleophysic dysplasia is a rare genetic condition characterized by short stature, distinctive facial features, skeletal abnormalities, and heart valve abnormalities. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously. In the context of Geleophysic dysplasia type 2, NGS genetic testing can be used to identify specific mutations or variants in the FBN1 gene that are associated with this condition. By performing NGS genetic testing, healthcare professionals can diagnose Geleophysic dysplasia type 2, confirm the presence of specific mutations in the FBN1 gene, and provide appropriate medical management and genetic counseling for affected individuals and their families.

Test Name FBN1 Gene Geleophysic dysplasia type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for FBN1 Gene Geleophysic dysplasia type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FBN1 Gene Geleophysic dysplasia type 2 NGS Genetic DNA Test gene FBN1
Test Details

The FBN1 gene is associated with a genetic disorder called Geleophysic dysplasia type 2. Geleophysic dysplasia is a rare genetic condition characterized by short stature, distinctive facial features, skeletal abnormalities, and heart valve abnormalities.

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously. In the context of Geleophysic dysplasia type 2, NGS genetic testing can be used to identify specific mutations or variants in the FBN1 gene that are associated with this condition.

By performing NGS genetic testing, healthcare professionals can diagnose Geleophysic dysplasia type 2, confirm the presence of specific mutations in the FBN1 gene, and provide appropriate medical management and genetic counseling for affected individuals and their families.